Results

Lactobacillus rhamnosus F-1 is a product whose strain origin is isolated from healthy women's vaginas with no microbial domestication or mutation process. Applications include promoting vaginal health, anti-inflammation, oral care, and stomach health. The production process involves fermentation, centrifuging, freeze-drying, and packaging.

Lactobacillus rhamnosus MP108 is a product whose strain origin is isolated from healthy infants' intestines with no microbial domestication or mutation process. Its applications encompass intestine health, immune health, and oral health. Labeling claims highlight non-toxicity, non-hazardousness, and biodegradability. End uses include infant formula, dietary supplements, and functional foods.

Lactobacillus rhamnosus bv-77 is a product whose strain origin is isolated from healthy human breast milk with no microbial domestication or mutation process. It is applied for the regulation of fat metabolism, gut health, pathogen inhibition, vaginal health, and as an antioxidant. The production process involves fermentation, centrifuging, freeze-drying, and packaging.